WEZO
The computed 12-month bankruptcy probability of WEZO is 0.1% (very low). The 2024 annual accounts show equity of €1.30M and a net result of €752. Equity is growing by ~6.2% per year across the filed fiscal years. Its solvency ranks better than 60% of 379 sector peers (fiscal year 2024). The company has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €1.30M |
| Net result | €752 |
| Staff (FTE) | 4.3 |
| Better than sector | 60% |
Strong profile, led by stability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 64.4% | 50.4% | |
| Net result | €752 | €71k | |
| Equity | €1.30M | €127k | |
| Gross operating margin | €309k | €179k | |
| Staff costs | €179k | €132k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €127k |
| Net profit | €752 |
| Cash flow | €81k |
| Staff costs | €179k |
| Income taxes | €9k |
| Dividends | - |
| Total assets | €2.03M |
| Equity | €1.30M |
| Debt | €722k |
| of which ≤ 1y | €343k |
| of which > 1y | €338k |
| Working capital | €1.49M |
| Employees (FTE) | 4.3 |
| 2024 | |
|---|---|
| Current ratio | 5.35 |
| Quick ratio | 5.35 |
| Working capital ratio | 73.7% |
| Solvency | 64.4% |
| Debt / equity | 0.55 |
| Long-term debt ratio | 0.26 |
| Interest coverage | 4.44 |
| Gross margin | - |
| Net margin | - |
| ROA | 0.0% |
| ROE | 0.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2.03M |
| Fixed assets | 21/28 | €190k |
| Tangible fixed assets | 22/27 | €190k |
| Current assets | 29/58 | €1.84M |
| Amounts receivable within one year | 40/41 | €11k |
| Investments | 50/53 | €399k |
| Cash & bank | 54/58 | €514k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2.03M |
| Equity | 10/15 | €1.30M |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €1.29M |
| Amounts payable | 17/49 | €722k |
| Amounts payable after one year | 17 | €338k |
| Amounts payable within one year | 42/48 | €343k |
| Trade debts payable within one year | 44 | €267k |
| Income statement | ||
| Gross operating margin | 9900 | €309k |
| Operating result | 9901 | €47k |
| Financial income | 75 | €10k |
| Financial charges | 65 | €29k |
| Result before taxes | 9903 | €10k |
| Income taxes | 67/77 | €9k |
| Net result for the period | 9904 | €752 |
| Result to be appropriated | 9905 | €752 |
| NACE primary | Human health(86230) |
| Legal form | Private limited company(610) |
| Incorporation | 30-03-1995 |
| Status | Active |
| Postal code | 9230 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 42028A1279/00E002 | Flanders | 401 m² | 1 · 401 m² | 16.6 m · 5 fl. |
| 42302E0474/00B000 | Flanders | 232 m² | 1 · 232 m² | 12.2 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
01-12-2023 All shares are now held by a single shareholder
Technical details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "reserves_incorporation",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "suppress"
},
{
"kind": "share_buyback",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inkoop_eigen_aandelen",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_split",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
}
],
"notary": {
"name": "Annelies Wylleman",
"firm_city": null,
"firm_name": "Notariaat Sleidinge geassocieerde notarissen",
"office_city": "Evergem-Sleidinge",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2023-12-01",
"filing_date": "2023-11-29",
"act_kind_objet": "WIJZIGING RECHTSVORM, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), ONTSLAGEN, BENOEMINGEN, KAPITAAL, AANDELEN"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-11-24",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0454.902.482",
"name_full": "WEZO",
"legal_form": "Besloten vennootschap met beperkte aansprakelijkheid",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition pv buitengewone algemene vergadering",
"co\u00F6rdinatie van de statuten"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Peter De Wilde",
"role": "simple_associ\u00E9",
"n_shares": 200,
"share_class": null
},
{
"kbo": "0439.469.683",
"pct": null,
"kind": "org",
"name": "IMMO LIFA",
"role": "simple_associ\u00E9",
"n_shares": 50,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Ann Fran\u00E7ois",
"role": "simple_associ\u00E9",
"n_shares": 50,
"share_class": null
}
],
"share_classes_after": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | WEZO |